XRTX Xyratex Ltd.

-

Xyratex Reported Earnings

Friday, August 14, 2026 · 12:00 AM ET

Xyratex (XRTX) reported a loss of $1.05 per share on revenue of $0.00 million for the . .

XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.

Earnings Whisper Grade
Power Rating
Reported Earnings
($1.05)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth-10.5 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth